Coronavirus Update: Pfizer/BioNTech Commit 500m Doses For US Donations
Merck & Co. Signs $1.2bn US Deal For Antiviral Pill
The US obtained access to doses that it will donate to low- and low-middle-income countries, Merck & Co. is lining up government purchases of its Phase III drug, and Ocugen will submit a BLA in the US rather than pursue an EUA for Bharat's vaccine. Plus progress and setbacks for COVID-19 therapeutics.
